Stocks Health care INGN
NASDAQ · Health careInogen Inc (INGN)
Inogen Inc brought in $352.4M of revenue over the twelve months to September 30, 2026, up 5.6% from a year earlier. It posted a net loss of $35.5M. In fiscal 2025 capital spending exceeded operating cash flow by $13.7M. At September 30, 2026 it held $81.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 9, 2026.
Key facts about Inogen Inc
- Net worth
- Inogen Inc has a market value (market cap) of $162.3M at the latest share price, and shareholders' equity of $157M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $348.7M (+3.9% year on year), with a net loss of $22.7M. Over the 12 months to September 30, 2026: revenue $352.4M, net loss $35.5M.
- Cash flow
- In fiscal 2025 operations used $11.2M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 9, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Inogen Inc's next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Inogen Inc does
Inogen Inc is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker INGN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $348.7M | -$22.7M | -$0.86 | -$13.7M |
| 2024 | $335.7M | -$35.9M | -$1.52 | $2.6M |
| 2023 | $315.7M | -$102.4M | -$4.42 | -$8.5M |
| 2022 | $377.2M | -$83.8M | -$3.67 | -$40.9M |
| 2021 | $358M | -$6.3M | -$0.28 | $18.2M |
| 2020 | $308.5M | -$5.8M | -$0.27 | $32.6M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where INGN ranks in Health care
Latest SEC filings
What Inogen Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 2.4% to $77.2M versus the same quarter last year; diluted EPS -$0.61 versus -$0.20.
- November 5, 2026
- September 30, 2026Material agreement8-KInogen agreed to sell its United States oxygen rental business to Rotech Healthcare for up to approximately $24.8 million and entered into a long-term supply agreement.
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 3% to $95.1M versus the same quarter last year; diluted EPS -$0.14 versus -$0.15.
- August 6, 2026
- July 24, 2026
- July 1, 2026
- June 12, 2026
- June 11, 2026
- May 28, 2026
Insider trades
What the people running Inogen Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 5 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 1, 2026 | Smith Kevin Raymond MerrillCEO and President, Director | Received as pay | 1,500 | $8K |
| September 1, 2026 | Smith Kevin P.EVP, Bus Dev, GC & Sec | Received as pay | 1,500 | $8K |
| September 1, 2026 | Smith Kevin P.EVP, Bus Dev, GC & Sec | Exercised options | 18,136 | - |
| September 1, 2026 | Smith Kevin P.EVP, Bus Dev, GC & Sec | Shares withheld for tax | 8,671 | $46.2K |
| September 1, 2026 | Wright Mary EVP, Chief Accounting Officer | Received as pay | 1,500 | $8K |
| July 1, 2026 | Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR Off | Soldpre-planned (10b5-1) | 10,938 | $72.1K |
| June 5, 2026 | King Kevin MDirector | Received as pay | 28,081 | - |
| June 5, 2026 | Mora ElizabethDirector | Received as pay | 28,081 | - |
Who owns INGN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Yuwell (Hong Kong) Holdings Limited13G, passive with 1 related filers | 9.9% | February 24, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 129 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 1,748,986 | +101,902 |
| Armistice Capital, LLC | 1,096,000 | -104,000 |
| Vanguard Capital Management LLC | 1,038,316 | +1,611 |
| Ameriprise Financial Inc | 983,028 | +123,485 |
| Aqr Capital Management LLC | 937,334 | +510,216 |
| DAFNA Capital Management LLC | 845,179 | 0 |
| Arrowstreet Capital, Limited Partnership | 743,252 | +157,093 |
| Morgan Stanley | 646,276 | +105,111 |
| Geode Capital Management, LLC | 641,521 | +27,992 |
| State Street Corp | 591,943 | +18,739 |
| Federated Hermes, Inc. | 534,936 | +20,280 |
| Jpmorgan Chase & Co | 480,308 | +52,652 |
| Dimensional Fund Advisors LP | 488,645 | -21,177 |
| Renaissance Technologies LLC | 476,700 | -2,100 |
| Goldman Sachs Group Inc | 435,585 | -144,515 |
| ExodusPoint Capital Management, LP | 393,803 | +63,362 |
| Jacobs Levy Equity Management, Inc | 388,788 | +91,819 |
| Prudential Financial Inc | 328,970 | -40,100 |
| UBS Group AG | 301,596 | +117,087 |
| Moore Capital Management, LP | 289,128 | +9,229 |
Insiders
13 insiders reported holding 981,754 shares in total, about $6M at the last price.
| Holder | Shares |
|---|---|
| Smith Kevin Raymond MerrillCEO and President, Director | 134,962 |
| Rider Heather D.Director | 116,282 |
| Mora ElizabethDirector | 107,261 |
| King Kevin MDirector | 104,966 |
| Boehnlein Glenn SDirector | 104,966 |
| Ladone Mary KayDirector | 104,966 |
| Bourque Michael J.EVP, CFO & Treasurer | 94,596 |
| Sahney Mira KirtiDirector | 67,805 |
| Ramade GregoireChief Commercial Officer | 44,229 |
| Jamali VafaDirector | 43,081 |
Questions about INGN
What does Inogen Inc do?
Inogen Inc is a company in the Health care sector, listed on NASDAQ as INGN. Its shares trade on NASDAQ under the ticker INGN.
What is Inogen Inc's net worth?
Inogen Inc has a market value (market cap) of $162.3M at the latest share price, and shareholders' equity of $157M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Inogen Inc profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $35.5M on revenue of $352.4M.
How much revenue does Inogen Inc make?
Over the twelve months to September 30, 2026 Inogen Inc reported revenue of $352.4M. That is 5.6% more than a year earlier.
When did Inogen Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 9, 2026. It covers the period to September 30, 2026.
When is Inogen Inc's next earnings report?
Inogen Inc's next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare INGN with
Follow INGN
Get an email when Inogen Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Inogen Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.